References
- Cozzi DA, Mele E, Ceccanti S, Natale F, Clerico A, Schiavetti A, Dominici C. 2013. Long-term follow-up of the “wait and see” approach to localized perinatal adrenal neuroblastoma. World Journal of Surgery 37:459–465.
- Cun L, Zhe M, Xinfeng Z, Guowei T, Shaoping L, Chuanxi L. 2008. Fetal neuroblastoma with fetal hypertension. Ultrasound in Obstetrics and Gynecology 31:106–107.
- Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, et al. 2008. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. Journal of Clinical Oncology 26:1504–1510.
- Inoue T, Ito Y, Nakamura T, Matsuoka K, Sago H. 2014. A catecholamine-secreting neuroblastoma leading to hydrops fetalis. Journal of Perinatology 34:405–407.
- Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, et al. 2011. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754.
- Lindner W, Behnisch W, Kunz U, Debatin KM, Pohlandt F. 2001. Congenital neuroblastoma mimicking early onset sepsis. European Journal of Paediatrics 160:436–438.
- Maki E, Oh K, Rogers S, Sohaey R. 2014. Imaging and differential diagnosis of suprarenal masses in the fetus. Journal of Ultrasound in Medicine 33:895–904.
- Sauvat F, Sarnacki S, Brisse H, Medioni J, Rubie H, Aigrain Y, et al. 2002. Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer 94:2474–2480.
- Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, et al. 2004. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379.